|
English
|
正體中文
|
简体中文
|
2815453
|
|
???header.visitor??? :
27425778
???header.onlineuser??? :
649
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"liang s k"???jsp.browse.items-by-author.description???
Showing items 1-10 of 137 (14 Page(s) Totally) 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page
臺大學術典藏 |
2022-06-27T07:02:05Z |
Performance assessment of the DR. TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous mycobacteria
|
Lee M.-R.; Cheng A.; Huang Y.-T.; Liu C.-Y.; Chung K.-P.; Wang H.-C.; Liang S.-K.; Liao C.-H.; CHONG-JEN YU; Hsueh P.-R. |
臺大學術典藏 |
2022-06-27T07:01:54Z |
Evaluating pleural ADA, ADA2, IFN-�^ and IGRA for diagnosing tuberculous pleurisy
|
Keng L.-T.; Shu C.-C.; Chen J.Y.P.; Liang S.-K.; Lin C.-K.; Chang L.-Y.; Chang C.-H.; Wang J.-Y.; CHONG-JEN YU; Lee L.-N. |
臺大學術典藏 |
2022-06-27T07:00:05Z |
Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation
|
Keng L.-T.; Chung K.-P.; Lin S.-Y.; Liang S.-K.; Cheng J.-C.; Chen I.-C.; Chen Y.-F.; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; CHONG-JEN YU |
臺大學術典藏 |
2022-06-27T06:59:38Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; CHONG-JEN YU |
國立成功大學 |
2022 |
Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan
|
Chien, L.-H.;Chen, T.-Y.;Chen, Chen C.-H.;Chen, K.-Y.;Hsiao, C.-F.;Chang, G.-C.;Tsai, Y.-H.;Su, W.-C.;Huang, M.-S.;Chen, Y.-M.;Chen, Chen C.-Y.;Liang, S.-K.;Chen, Chen C.-Y.;Wang, C.-L.;Hung, Hung H.-H.;Jiang, H.-F.;Hu, J.-W.;Rothman, N.;Lan, Q.;Liu, T.-W.;Chen, Chen C.-J.;Yang, P.-C.;Chang, I.-S.;Hsiung, C.A. |
臺大學術典藏 |
2021-10-04T07:15:48Z |
Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates
|
Lee M.-R.; JEN-CHANG KO; Liang S.-K.; Lee S.-W.; Yen D.H.-T.; Hsueh P.-R. |
臺大學術典藏 |
2021-10-04T07:15:44Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y. |
臺大學術典藏 |
2021-10-04T07:15:44Z |
Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
|
Pan C.-H.; Chang Y.-F.; Lee M.-S.; Wen B.-C.; JEN-CHANG KO; Liang S.-K.; Liang M.-C. |
臺大學術典藏 |
2021-10-04T07:15:41Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y. |
臺大學術典藏 |
2021-10-04T07:15:39Z |
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
|
Liang S.-K.; JEN-CHANG KO; Yang J.C.-H.; Shih J.-Y. |
Showing items 1-10 of 137 (14 Page(s) Totally) 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page
|